Manning & Napier Group's GMAB Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 54 shares of Genmab A/S (GMAB) worth $1,395, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Manning & Napier Group has initiated a new position in GMAB, representing a fresh investment thesis on this company. Largest reduction occurred in Q1 2026, reducing 18 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Genmab A/S (GMAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Genmab A/S (GMAB) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -18 | Reduce 25.00% | 54 | $25.83 |
| Q4 2025 | +72 | New Buy | 72 | $31.49 |
Manning & Napier Group's Genmab A/S Investment FAQs
Manning & Napier Group first purchased Genmab A/S (GMAB) in Q4 2025, acquiring 72 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Genmab A/S (GMAB) for 2 quarters since Q4 2025.
Manning & Napier Group's largest addition to Genmab A/S (GMAB) was in Q4 2025, adding 72 shares worth $2,267.
According to the latest 13F filing for Q1 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 54 shares of Genmab A/S (GMAB), valued at approximately $1,395.
As of the Q1 2026 filing, Genmab A/S (GMAB) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Genmab A/S (GMAB) was 72 shares, as reported at the end of Q4 2025.